|Articles|April 1, 2000

April 2000
Volume 6
Issue 4

Current and Potential Uses of Low Molecular Weight Heparin: A Review and an Economic Analysis

Author(s)Philip Seo, MD, Charles F. S. Locke, MD

Download PDF: Current and Potential Uses of Low Molecular Weight Heparin: A Review and an Economic Analysis

Articles in this issue

over 26 years ago

Article

Variation in Managing Asthma: Experience at the Medical Group Level in California

over 26 years ago

Article

Evaluation of Common Problems in Primary Care: Effects of Physician, Practice, and Financial Characteristics

over 26 years ago

Article

Mediation Training Enhances Conflict Management by Healthcare Personnel

over 26 years ago

Article

A National Inpatient Cost Estimate of Percutaneous Endoscopic Gastrostomy (PEG)-Associated Aspiration Pneumonia

over 26 years ago

Article

Eliminating Variation in Asthma Management

over 26 years ago

Article

Variations in Primary Medical Care: Influence of Health Plans and Practice Organizations

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

Current and Potential Uses of Low Molecular Weight Heparin: A Review and an Economic Analysis

Articles in this issue

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Trending on AJMC

Jeff Hunnicutt to Bring Community Oncology Roots to New Role as Navista COO

Isatuximab OBI Cuts Infusion Reactions: Xavier Leleu, MD, PhD

Semaglutide More Than Doubled Likelihood of MASH Resolution

Contributor: How Health Systems Can Rebalance Behavioral Health Access

Once-Daily Pill Zasocitinib Clears Psoriasis at Toughest Sites